Back
Pliant Therapeutics Stock Price Chart
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
45
PLRX
Pliant Therapeutics
Last Price:
12.85
Seasonality Move:
15.67%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing selling pressure, which indicates risk of future bearish movement.
Pliant Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.68 | Sell |
| 20-day SMA: | 14.58 | Sell |
| 50-day SMA: | 13.06 | Buy |
| 200-day SMA: | 13.52 | Buy |
| 8-day EMA: | 14.41 | Sell |
| 20-day EMA: | 14.22 | Sell |
| 50-day EMA: | 13.53 | Buy |
| 200-day EMA: | 13.84 | Sell |
Pliant Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.38 | Buy |
| Relative Strength Index (14 RSI): | 47.39 | Sell |
| Chaikin Money Flow: | -206210 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.28 - 15.2) | Sell |
| Bollinger Bands (100): | (11.46 - 14.1) | Buy |
Pliant Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Pliant Therapeutics Stock
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 13.77 while PLRX 8-day simple moving average is 14.68, which is a Sell signal.
- The stock price of PLRX is 13.77 while Pliant Therapeutics 20-day SMA is 14.58, which makes it a Sell.
- Pliant Therapeutics 50-day simple moving average is 13.06 while PLRX share price is 13.77, making it a Buy technically.
- PLRX stock price is 13.77 and Pliant Therapeutics 200-day simple moving average is 13.52, creating a Buy signal.
PLRX Technical Analysis vs Fundamental Analysis
Sell
45
Pliant Therapeutics (PLRX)
is a Sell
Is Pliant Therapeutics a Buy or a Sell?
-
Pliant Therapeutics stock is rated a Sell
The current Pliant Therapeutics [PLRX] share price is $13.77. The Score for PLRX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Pliant Therapeutics Stock Info
Market Cap:
837.95M
Price in USD:
13.77
Share Volume:
251.04K
Pliant Therapeutics 52-Week Range
52-Week High:
19.62
52-Week Low:
10.22
Sell
45
Pliant Therapeutics (PLRX)
is a Sell
Pliant Therapeutics Share Price Forecast
-
What is the Pliant Therapeutics stock price today?
The Pliant Therapeutics stock price is 13.77 USD today. -
Will PLRX stock go up or go down?
Pliant Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Pliant Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pliant Therapeutics is overvalued.
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 13.77 while PLRX 8-day exponential moving average is 14.41, which is a Sell signal.
- The stock price of PLRX is 13.77 while Pliant Therapeutics 20-day EMA is 14.22, which makes it a Sell.
- Pliant Therapeutics 50-day exponential moving average is 13.53 while PLRX share price is 13.77, making it a Buy technically.
- PLRX stock price is 13.77 and Pliant Therapeutics 200-day simple moving average is 13.84, creating a Sell signal.
Fundamental Analysis of Pliant Therapeutics
Is Pliant Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.74 per share, and a decrease next year of $0.31 per share.
Technical Analysis of Pliant Therapeutics
Should I short Pliant Therapeutics stock?
- PLRX Moving Average Covergence Divergence (MACD) indicator is 0.38, suggesting Pliant Therapeutics is a Buy
- Pliant Therapeutics Relative Strength Index (RSI) is 47.39, which suggest Pliant Therapeutics is oversold
- The Bollinger Bands (25) for Pliant Therapeutics is (13.28 - 15.2), which suggest Pliant Therapeutics is a Buy
- The Bollinger Bands (100) for Pliant Therapeutics is (11.46 - 14.1), which suggest Pliant Therapeutics is a Buy
* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.